pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·Jul 23·1 min read
save

Biopharma firms must prioritize hiring and retaining commercial talent for successful drug launches

Jul 23, 2026·read at BioSpace ↗Neutral

A BioSpace webinar brought together commercial leaders and a recruiting specialist to discuss how biopharma companies can better hire and keep commercial staff as they prepare for new product launches.

Job posting data from BioSpace shows a 38% year-over-year rise in sales, marketing and medical affairs positions in the past month, reflecting growing demand for launch-support roles.

Speakers noted that high demand gives candidates leverage, so firms must move quickly and respect candidates’ time. Amplity’s Margaret Blackwell said companies that streamline hiring and treat candidates as partners are more likely to secure top talent.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “Make or break: Commercial hires critical for success”

read at BioSpace ↗
865 words · retrieved Jul 23
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ELI LILLY COEli Lilly and CoLILLYPFIZERSEAGENUltragenyx Pharmaceutical Inc.
drugs
Rare Disease
topics
Oncology2Big PharmaRare Disease

related stories

  • 15h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • 1d agoNovartis’ and BMS’ paused CAR T trials, RevMed’s pancreatic cancer approval, more MFN dealsBioSpace
  • Jul 22Webinar: From Clinical to Commercial: Talent Strategies for Biopharma GrowthBioSpace
  • May 12A year after Vertex’s big launch, pain drug research faces a pivotal momentBioPharma Dive